Dow Down0.18% Nasdaq Up0.39%

Misonix Inc. (MSON)

6.70 Down 0.11(1.62%) Sep 2, 3:33PM EDT
ProfileGet Profile for:
Misonix Inc.
1938 New Highway
Farmingdale, NY 11735
United States - Map
Phone: 631-694-9555
Fax: 631-694-9412

Index Membership:N/A
Industry:Medical Appliances & Equipment
Full Time Employees:71

Business Summary 

Misonix, Inc. designs, develops, manufactures, and markets minimally invasive ultrasonic surgical device products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical applications. The company offers BoneScalpel cutting system, which is used for surgical procedures of the spine and on maxillofacial procedures; SonaStar surgical aspirator that is used to emulsify and remove soft and hard tumors; and SonicOne wound cleansing and debridement system for the removal of devitalized tissue and fibrin deposits while sparing viable cells. It also markets AutoSonix ultrasound cutting and coagulating system; and Lysonix ultrasound assisted liposuction device. The company sells its products through independent direct sales persons, sales agents, and distributors. It has operations in the United States, Australia, Europe, Asia, Canada, Mexico, South America, South Africa, and the Middle East. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Misonix Inc.

Key Executives 
Mr. Michael A. McManus Jr., J.D. , 71
Chairman, Chief Exec. Officer and Pres
Mr. Richard A. Zaremba , 59
Chief Financial Officer, Principal Accounting Officer, Sr. VP, Treasurer and Sec.
Mr. Dan Voic , 52
VP of R&D and Engineering
Mr. Robert Scott Ludecker , 47
VP of Global Sales and Marketing
Mr. Ronald Manna , 59
VP of Quality and Regulatory Affairs
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders